
####### Feature 13 ##########



Insurers Eye Ivan the Terrible How will companies and investors fare if the storm spawns moderate damage?	1.0

Insurer lowers hurricane estimate Hurricane Charley, the worst storm to hit the US in over a decade, will cost insurers just \$7.4bn, one insurance expert estimates.	1.0

UPDATE 3-Walgreen profit rises, more stores planned Walgreen Co. (WAG.N: Quote, Profile, Research), the top US drugstore chain, on Monday said quarterly profit rose 18 percent on strong sales of prescription drugs 	1.0

US Treasuries cut early gains on jobless drop US Treasury debt prices cut early gains but remained narrowly higher after the government said that new claims for jobless insurance fell in the latest week.	1.0

Bank sits tight on rates as house price inflation eases off By Malcolm Moore, Economics Correspondent (Filed: 10/09/2004). The Bank of England held interest rates at 4.75pc yesterday after a series of recent surveys showed the housing market was slowing down.	1.0

ANOTHER VOICE Sugary drinks bad for you Many studies have linked the consumption of nondiet soda and fruit juices with added sugars to obesity and attendant risks of diabetes.	1.0

CBA to purchase local lender #39;s share Commonwealth Bank of Australia (CBA) said yesterday it was in talks with the Jinan City Commercial Bank (JNCCB) about buying a stake in the regional lender.	1.0

HK walks out of 68-month deflation cycle, official Hong Kong Financial Secretary Henry Tang said he believed Hong Kong has walked out of the consumer price deflation cycle that lingered for 68 months, according to the consumer price index trend in the past few years.	1.0

Walgreen 4th-Qtr Net Rises 18 Percent on Drug Sales (Update1) Walgreen Co., the largest US drugstore chain, said fourth-quarter profit rose 18 percent, helped by sales of prescription drugs. Net income had its biggest gain in almost two years, climbing 	1.0

Pfizer: Exubera Does Well in Trials Drug makers Pfizer Inc. and Sanofi-Aventis on Tuesday posted positive results from mid-stage trials of an inhaled insulin product for diabetics.	1.0
